Literature DB >> 1546848

Induction of emphysema in hamsters by intratracheal instillation of cathepsin B.

M Lesser1, M L Padilla, C Cardozo.   

Abstract

Current theories of pathogenesis suggest that pulmonary emphysema develops in humans because of progressive loss or derangement of lung elastin through a process mediated by elastolytic enzymes released by inflammatory cells. Neutrophils are considered primary etiologic factors because these cells produce and release two potent serine proteinases that cause emphysema when instilled into the lungs of animals. It has been suggested that alveolar macrophages also contribute to the development of emphysema through production of several enzymes with elastolytic activity, including the lysosomal cysteine proteinases cathepsin B and cathepsin L, but this has not been verified experimentally. In the current study, we instilled 115 micrograms of active cathepsin B into the lungs of hamsters three times at 48-h intervals. After 6 wk microscopic evaluation revealed that lung sections of five of seven animals given cathepsin B contained focal areas of enlarged and distorted alveoli, in the absence of fibrosis, which were similar to changes seen in the lungs of animals given papain intratracheally. Morphometrically, mean linear intercept (micron) values were significantly higher (p less than 0.025) in animals given cathepsin B (204.4 +/- 20.8) as compared with control animals (173.2 +/- 7.8), and internal surface area (sqcm) values were significantly lower (935 +/- 120 versus 1,083 +/- 56 in control animals), thereby confirming that airspace enlargement had developed after instillation of the enzyme. Lung volumes (ml) and compliance (ml/cm H2O) were not significantly higher in animals given cathepsin B.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1546848     DOI: 10.1164/ajrccm/145.3.661

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

1.  Serum cystatin C and emphysema: results from the National Health and Nutrition Examination Survey (NHANES).

Authors:  Haala K Rokadia; Shikhar Agarwal
Journal:  Lung       Date:  2012-06       Impact factor: 2.584

2.  The multiple facets of alpha-1-antitrypsin.

Authors:  Robert A Stockley
Journal:  Ann Transl Med       Date:  2015-06

Review 3.  Animal models of chronic obstructive pulmonary disease.

Authors:  Joanne L Wright; Manuel Cosio; Andrew Churg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

Review 4.  Alpha-1 Antitrypsin Deficiency: Have We Got the Right Proteinase?

Authors:  Robert A Stockley
Journal:  Chronic Obstr Pulm Dis       Date:  2020-07

5.  A murine model of elastase- and cigarette smoke-induced emphysema.

Authors:  Rubia Rodrigues; Clarice Rosa Olivo; Juliana Dias Lourenço; Alyne Riane; Daniela Aparecida de Brito Cervilha; Juliana Tiyaki Ito; Milton de Arruda Martins; Fernanda Degobbi Tenório Quirino Dos Santos Lopes
Journal:  J Bras Pneumol       Date:  2017 Mar-Apr       Impact factor: 2.624

6.  Comparative transcriptomics in human COPD reveals dysregulated genes uniquely expressed in ferrets.

Authors:  Shah S Hussain; Yvonne J K Edwards; Emily Falk Libby; Denise Stanford; Stephen A Byzek; Don D Sin; Merry-Lynn McDonald; S Vamsee Raju; Steven M Rowe
Journal:  Respir Res       Date:  2022-10-10

Review 7.  Evidences of Herbal Medicine-Derived Natural Products Effects in Inflammatory Lung Diseases.

Authors:  Fernanda Paula R Santana; Nathalia M Pinheiro; Márcia Isabel B Mernak; Renato F Righetti; Mílton A Martins; João H G Lago; Fernanda D T Q Dos Santos Lopes; Iolanda F L C Tibério; Carla M Prado
Journal:  Mediators Inflamm       Date:  2016-06-29       Impact factor: 4.711

8.  The cytoprotective role of DJ-1 and p45 NFE2 against human primary alveolar type II cell injury and emphysema.

Authors:  Li Hui Tan; Karim Bahmed; Chih-Ru Lin; Nathaniel Marchetti; Sudhir Bolla; Gerard J Criner; Steven Kelsen; Muniswamy Madesh; Beata Kosmider
Journal:  Sci Rep       Date:  2018-02-23       Impact factor: 4.379

9.  Copper-Heparin Inhalation Therapy To Repair Emphysema: A Scientific Rationale.

Authors:  Rob Janssen; Emiel Fm Wouters; Wim Janssens; Willeke F Daamen; Paul Hagedoorn; Hugo Ajm de Wit; Jef Serré; Ghislaine Gayan-Ramirez; Frits Me Franssen; Niki L Reynaert; Jan H von der Thüsen; Henderik W Frijlink
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-11-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.